What is the current Price Target for the Pieris Pharmaceuticals, Inc. stock?

The average Pieris Pharmaceuticals, Inc. target price is $34.00. This is 150.00% higher than the current stock price. The highest price target is 179.41%, the lowest is 120.59%. 2 Analysts have issued a price target Pieris Pharmaceuticals, Inc. 2025 .

How high will the Pieris Pharmaceuticals, Inc. stock rise?

No reliable answer can be given as to how high the Pieris Pharmaceuticals, Inc. stock will rise. The performance of stocks, including the Pieris Pharmaceuticals, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Pieris Pharmaceuticals, Inc. stock today?

The performance of Pieris Pharmaceuticals, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Pieris Pharmaceuticals, Inc. stock fall?

The decline in Pieris Pharmaceuticals, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Pieris Pharmaceuticals, Inc. Forecast, price target & analysts

$13.60

0.00%

Nasdaq, Fri, Dec 27 2024

ISIN

US7207951036

Symbol

PIRS

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Pieris Pharmaceuticals, Inc. Target price 2024 - Analyst rating & recommendation

Pieris Pharmaceuticals, Inc. Classifications & Recommendation:

Buy

100%

Pieris Pharmaceuticals, Inc. Price Target

Target Price	$34.00
Price	$13.60
Potential	150.00% register free of charge
Number of Estimates	2

	2 Analysts have issued a price target Pieris Pharmaceuticals, Inc. 2025 . The average Pieris Pharmaceuticals, Inc. target price is $34.00. This is 150.00% register free of charge higher than the current stock price. The highest price target is $38.00 179.41% register free of charge , the lowest is $30.00 120.59% register free of charge .
	A rating was issued by 2 analysts: 2 Analysts recommend Pieris Pharmaceuticals, Inc. to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Pieris Pharmaceuticals, Inc. stock has an average upside potential 2025 of 150.00% register free of charge . Most analysts recommend the Pieris Pharmaceuticals, Inc. stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '23	2024 Estimates
Revenue Million $	42.81	0.03
	65.29%	99.94%

2 Analysts have issued a sales forecast Pieris Pharmaceuticals, Inc. 2024 . The average Pieris Pharmaceuticals, Inc. sales estimate is

Unlock

. This is

Unlock

than the revenue of the last 12 months(TTM). The highest sales forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics:

2023	$42.8m	65.29%
2024	$26.5k 99.94% Unlock
2025	$0.0 100.00% Unlock
2028	$45.6m 953.44% Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '23	2024 Estimates
EV/Sales		3,537.74

Based on analysts' sales estimates for 2024, the Pieris Pharmaceuticals, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

Unlock

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of

Unlock

This results in the following potential growth metrics and future valuations:

Current	69.44	19,388.89%
2024	3,537.74 4,994.67% Unlock
2028	2.06 90.51% Unlock

Current	83.79	25,366.63%
2024	4,268.30 4,994.34% Unlock
2028	2.48 90.51% Unlock

Pieris Pharmaceuticals, Inc....

Discover more stocks with a high price target

Valneva 268.86%

CureVac N.V. 114.53%

Moderna 77.92%

Bavarian Nordic 59.49%

Teamviewer 56.15%

RWE 47.84%

Nel ASA 47.09%

Alibaba Group Holding Ltd 43.74%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now